// App-Quantinova.ai

498 : Meta-analysis of genomic aberrations identified in CTCs andctDNA in triple negative breast cancer

Researchers

Presenter

  • Kellie Howard

Principal Investigators

  • Fang Yin Lo

  • Arturo Ramirez

  • Debbie Boles

  • John Pruitt

  • Elisabeth Mahen

  • Heather Collins

  • Amanda Leonti

  • Lindsey Maassel

  • Christopher Subia

  • Tuuli Saloranta

  • Nicole Christopherson

  • Kerry Deutsch

  • Jackie Stilwell

  • Eric Kaldjian

  • Michael Dorschner

  • Sibel Blau

  • Anthony Blau

  • Marcia Eisenberg

  • Steven Anderson

  • Anup Madan

Medical Centers

  • Covance, Seattle, WA

  • RareCyte Inc., Seattle, WA

  • Laboratory Corporation of Amcerica, Research Triangle Park, NC

  • Center for Cancer Innovation, University of Washington, Seattle, WA

  • Northwest Medical Specialties, PLLC, Puyallup, WA

  • Covance, Durham, NC

Locations

  • United States

Companies

  • Laboratory Corporati

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Circulating tumor cells

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A